Top Markets
#1 Black Phoenix Black Phoenix +367.56%
#2 Islamic Coin Islamic Coin +158.20%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.03%
#5 Akedo Akedo +41.87%
#6 Acurast Acurast +35.56%
#7 BasedHype BasedHype +29.98%
#8 GoPlus Security GoPlus Security +22.00%
#9 Cryptopia Cryptopia +21.42%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +21.15%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
株式のランク #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
株価
$0.0202
最終同期: 2024-11-19
時価総額
$44.67K
変化（1日）
-0.49%
変化（1年）
0.00%
国
IL
取引 Notable Labs, Ltd. (NTBL)

カテゴリー

Healthcare
Notable Labs, Ltd.（NTBL）の発行済株式数
June 2024 時点の発行済株式数 9.46M
Notable Labs, Ltd. の最新の財務報告および株価によると、現在の発行済株式数は 9.46M です。December 2022 の終わりには、同社は 2.22M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Notable Labs, Ltd.（NTBL）の発行済株式数の履歴（2015 ～ 2026）
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 9.46M 322.17%
2023 2.24M 1.08%
2022 2.22M -96.97%
2021 73.05M 44.56%
2020 50.53M 0.00%
2019 50.53M 53.27%
2018 32.97M 20.33%
2017 27.40M 9.72%
2016 24.97M 22.95%
2015 20.31M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 2,585.14%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 557.65%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE